Zhan and Chiba et al. studied HOXB9 expression to mediate angiogenesis, EMT and tumor stem cell properties through the TGF-β pathway, leading to chemoresistance and poor overall prognosis in pancreatic cancer [46, 47]. The gene discussed is HOXB9; the disease is familial pancreatic carcinoma.